halothane has been researched along with mivazerol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gobert, J; Guyaux, M; Noyer, M; Vandevelde, M; Wülfert, E | 1 |
| Hanin, I; Kindel, G; Wülfert, E; Zhang, X | 1 |
2 other study(ies) available for halothane and mivazerol
| Article | Year |
|---|---|
Mivazerol prevents the tachycardia caused by emergence from halothane anesthesia partly through activation of spinal alpha 2-adrenoceptors.
Topics: Adrenergic alpha-Agonists; Anesthetics, Inhalation; Animals; Halothane; Heart Rate; Imidazoles; Male; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Spinal Cord; Yohimbine | 1998 |
Mivazerol inhibits intrathecal release of glutamate evoked by halothane withdrawal in rats.
Topics: Adrenergic alpha-Agonists; Anesthesia; Anesthetics, Inhalation; Animals; Aspartic Acid; Blood Pressure; Glutamic Acid; Halothane; Heart Rate; Imidazoles; Male; Microdialysis; Rats; Rats, Sprague-Dawley; Spinal Cord; Substance Withdrawal Syndrome | 1998 |